R&D Systems™ Human FGF-18, Carrier-Free Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 8988F18050
DescriptionThe Recombinant Human FGF-18 Protein is derived from E. coli. The Recombinant Human FGF-18 Protein has been validated for the following applications: Bioactivity.
|E. coli-derived Glu28-Ala207, with a N-terminal Met|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining|
|E. coli-derived human FGF-18 protein Glu28-Ala207,with a N-terminal Met|
|<0.10 EU per 1μg of the protein by the LAL method.|
|Measured in a cell proliferation assay using BaF3 mouse pro-B cells transfected with human FGF RIIIc. The ED50 for this effect is typically 4-24ng/mL|
|Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 EDTA and Trehalose.|
|Observed M.W.: 19-24kDa, reducing conditions, Theoretical M.W.: 21kDa|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
|FGF18, FGF-18ZFGF5, fibroblast growth factor 18, zFGF5|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok